(Q45880394)

17 December 2017

title

Gene therapy matures in the clinic (English)

1 reference

17 December 2017

0 references

Adrian J Thrasher

2

0 references

author name string

Leonard W Seymour

series ordinal

1

1 reference

17 December 2017

publication date

10 July 2012

1 reference

17 December 2017

published in

Nature Biotechnology

1 reference

17 December 2017

volume

30

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

588-593

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/nbt.2290

exact match

0 references

cites work

Effect of gene therapy on visual function in Leber's congenital amaurosis

1 reference

Safety and efficacy of gene transfer for Leber's congenital amaurosis

21 January 2018

1 reference

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

21 January 2018

1 reference

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B

21 January 2018

1 reference

Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges

21 January 2018

1 reference

Gene therapy for primary immunodeficiency

21 January 2018

1 reference

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

21 January 2018

1 reference

Therapeutic exon skipping for dysferlinopathies?

21 January 2018

1 reference

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors

21 January 2018

1 reference

HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency

21 January 2018

1 reference

In vivo genome editing restores haemostasis in a mouse model of haemophilia

21 January 2018

1 reference

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

21 January 2018

1 reference

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

21 January 2018

1 reference

Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors

21 January 2018

1 reference

REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer

21 January 2018

1 reference

OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma

21 January 2018

1 reference

Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy

21 January 2018

1 reference

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

21 January 2018

1 reference

Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

Efficacy of gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction

21 January 2018

1 reference

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

21 January 2018

1 reference

Gene therapy of chronic granulomatous disease: the engraftment dilemma

21 January 2018

1 reference

Stem-cell gene therapy for the Wiskott-Aldrich syndrome

21 January 2018

1 reference

Gene therapy for the Wiskott-Aldrich syndrome

21 January 2018

1 reference

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

21 January 2018

1 reference

Inducible apoptosis as a safety switch for adoptive cell therapy

21 January 2018

1 reference

Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

21 January 2018

1 reference

Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22781675

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NBT.2290

1 reference

17 December 2017

Dimensions Publication ID

1013750838

0 references

1 reference

17 December 2017